Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2014 (2014), Article ID 867289, 15 pages
http://dx.doi.org/10.1155/2014/867289
Research Article

Systematic Analysis of Time-Series Gene Expression Data on Tumor Cell-Selective Apoptotic Responses to HDAC Inhibitors

1National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun 130024, China
2School of Computer Science and Information Technology, Northeast Normal University, Changchun 130117, China
3Department of General Internal Medicine, First Hospital of Jilin University, Changchun 130021, China
4Research Center of Agriculture and Medicine Gene Engineering of Ministry of Education, Northeast Normal University, Changchun 130024, China

Received 13 June 2014; Accepted 7 August 2014; Published 13 October 2014

Academic Editor: Hsueh-Fen Juan

Copyright © 2014 Yun-feng Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Khan and N. B. La Thangue, “Drug Insight: Histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas,” Nature Clinical Practice Oncology, vol. 5, no. 12, pp. 714–726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Song, J. H. Noh, J. H. Lee et al., “Increased expression of histone deacetylase 2 is found in human gastric cancer,” APMIS, vol. 113, no. 4, pp. 264–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. Krusche, P. Wülfing, C. Kersting et al., “Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis,” Breast Cancer Research and Treatment, vol. 90, no. 1, pp. 15–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. C. Spurling, C. A. Godman, E. J. Noonan, T. P. Rasmussen, D. W. Rosenberg, and C. Giardina, “HDAC3 overexpression and colon cancer cell proliferation and differentiation,” Molecular Carcinogenesis, vol. 47, no. 2, pp. 137–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. W.-S. Wu, S. Vallian, E. Seto et al., “The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases,” Molecular and Cellular Biology, vol. 21, no. 7, pp. 2259–2268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. F. F. Ferrara, F. Fazi, A. Bianchini et al., “Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia,” Cancer Research, vol. 61, no. 1, pp. 2–7, 2001. View at Google Scholar · View at Scopus
  7. O. Khan, S. Fotheringham, V. Wood et al., “HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 14, pp. 6532–6537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Grant, C. Easley, and P. Kirkpatrick, “Vorinostat,” Nature Reviews Drug Discovery, vol. 6, no. 1, pp. 21–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. M. Richon, “Targeting histone deacetylases: development of vorinostat for the treatment of cancer,” Epigenomics, vol. 2, no. 3, pp. 457–465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. K. Lindemann, A. Newbold, K. F. Whitecross et al., “Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 19, pp. 8071–8076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Insinga, S. Monestiroli, S. Ronzoni et al., “Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway,” Nature Medicine, vol. 11, no. 1, pp. 71–76, 2005. View at Google Scholar
  12. J.-H. Park, H.-S. Jong, S. G. Kim et al., “Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase,” Journal of Molecular Medicine, vol. 86, no. 1, pp. 117–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. E. Bolden, W. Shi, K. Jankowski et al., “HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses,” Cell Death and Disease, vol. 4, article e519, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ashburner, C. A. Ball, J. A. Blake et al., “Gene ontology: tool for the unification of biology,” Nature Genetics, vol. 25, no. 1, pp. 25–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Ogata, S. Goto, K. Sato, W. Fujibuchi, H. Bono, and M. Kanehisa, “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 27, no. 1, pp. 29–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Nishimura, “BioCarta,” Biotech Software & Internet Report, vol. 2, no. 3, pp. 117–120, 2001. View at Publisher · View at Google Scholar
  19. J. Ernst and Z. Bar-Joseph, “STEM: a tool for the analysis of short time series gene expression data,” BMC Bioinformatics, vol. 7, article 191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Liberzon, A. Subramanian, R. Pinchback, H. Thorvaldsdóttir, P. Tamayo, and J. P. Mesirov, “Molecular signatures database (MSigDB) 3.0,” Bioinformatics, vol. 27, no. 12, pp. 1739–1740, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Huang, A. Wallqvist, N. Thanki, and D. G. Covell, “Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action,” Pharmacogenomics Journal, vol. 5, no. 6, pp. 381–399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Huang, A. Wallqvist, and D. G. Covell, “Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen,” Genomics, vol. 87, no. 3, pp. 315–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Huang, A. Wallqvist, and D. G. Covell, “Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues,” Molecular Cancer Therapeutics, vol. 5, no. 9, pp. 2417–2427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Ernst, G. J. Nau, and Z. Bar-Joseph, “Clustering short time series gene expression data,” Bioinformatics, vol. 21, no. 1, pp. i159–i168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Salomonis, K. Hanspers, A. C. Zambon et al., “GenMAPP 2: new features and resources for pathway analysis,” BMC Bioinformatics, vol. 8, article 217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. W. Doniger, N. Salomonis, K. D. Dahlquist, K. Vranizan, S. C. Lawlor, and B. R. Conklin, “MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data,” Genome Biology, vol. 4, article R7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. D. R. Grayson, M. Kundakovic, and R. P. Sharma, “Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?” Molecular Pharmacology, vol. 77, no. 2, pp. 126–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. J. Bakkenist and M. B. Kastan, “DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation,” Nature, vol. 421, no. 6922, pp. 499–506, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Groselj, N. L. Sharma, F. C. Hamdy, M. Kerr, and A. E. Kiltie, “Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair,” British Journal of Cancer, vol. 108, no. 4, pp. 748–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Robert and F. V. Rassool, “HDAC inhibitors: roles of DNA damage and repair,” Advances in Cancer Research, vol. 116, pp. 87–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Loewer, K. Karanam, C. Mock, and G. Lahav, “The p53 response in single cells is linearly correlated to the number of DNA breaks without a distinct threshold,” BMC Biology, vol. 11, article 114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Mirzayans, B. Andrais, A. Scott, and D. Murray, “New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 170325, 16 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Cao, J. Li, J. Zhu et al., “The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity,” The Journal of Biological Chemistry, vol. 288, no. 47, pp. 34181–34189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Wu, B. Liu, Q. Zhang et al., “Dihydromyricetin reduced bcl-2 expression via p53 in human hepatoma HepG2 cells,” PLoS ONE, vol. 8, no. 11, Article ID e76886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Aoyama, K. Yaegaki, B. Calenic, H. Ii, N. Ishkitiev, and T. Imai, “The role of p53 in an apoptotic process caused by an oral malodorous compound in periodontal tissues: a review,” Journal of Breath Research, vol. 6, no. 1, Article ID 017104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Khan and N. B. la Thangue, “HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications,” Immunology and Cell Biology, vol. 90, no. 1, pp. 85–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Rikiishi, “Autophagic and apoptotic effects of HDAC inhibitors on cancer cells,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 830260, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Akada, S. Akada, A. Gajra et al., “Efficacy of vorinostat in a murine model of polycythemia vera,” Blood, vol. 119, no. 16, pp. 3779–3789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. K. B. Glaser, M. J. Staver, J. F. Waring, J. Stender, R. G. Ulrich, and S. K. Davidsen, “Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines,” Molecular Cancer Therapeutics, vol. 2, no. 2, pp. 151–163, 2003. View at Google Scholar · View at Scopus
  40. M. New, H. Olzscha, and N. B. la Thangue, “HDAC inhibitor-based therapies: can we interpret the code?” Molecular Oncology, vol. 6, no. 6, pp. 637–656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. C. G. Broustas and H. B. Lieberman, “DNA damage response genes and the development of cancer metastasis,” Radiation Research, vol. 181, no. 2, pp. 111–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Nielsen, I. B. Bentsen, A. H. Andersen, S. M. Gasser, and L. Bjergbaek, “A Rad53 independent function of Rad9 becomes crucial for genome maintenance in the absence of the RecQ helicase Sgs1,” PLoS ONE, vol. 8, no. 11, Article ID e81015, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Nasuno, S. Mimaki, M. Okamoto, H. Esumi, and K. Tsuchihara, “Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines,” Cancer Science, vol. 105, no. 2, pp. 202–210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Li and X. Yu, “Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation,” Cancer Cell, vol. 23, no. 5, pp. 693–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Heideker, E. T. Lis, and F. E. Romesberg, “Phosphatases, DNA damage checkpoints and checkpoint deactivation,” Cell Cycle, vol. 6, no. 24, pp. 3058–3064, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. U. Rashid, N. Muhammad, S. Faisal, A. Amin, and U. Hamann, “Constitutional CHEK2 mutations are infrequent in early-onset and familial breast/ovarian cancer patients from Pakistan,” BMC Cancer, vol. 13, article 312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Karim, Z. Mirza, M. I. Naseer, M. H. Al-Qahtani, and A. Ali, “Clinicopathological characteristics and chronology of p53 expression in the development of gastric cancer,” Hepato-Gastroenterology, vol. 60, no. 128, pp. 2113–2118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Koundrioukoff, S. Carignon, H. Técher, A. Letessier, O. Brison, and M. Debatisse, “Stepwise activation of the ATR signaling pathway upon increasing replication stress impacts fragile site integrity,” PLoS Genetics, vol. 9, no. 7, Article ID e1003643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Morita, K. Tanimoto, T. Murakami, T. Morinaga, and Y. Hosoi, “Mitochondria are required for ATM activation by extranuclear oxidative stress in cultured human hepatoblastoma cell line Hep G2 cells,” Biochemical and Biophysical Research Communications, vol. 443, no. 4, pp. 1286–1290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Kotsinas, P. Papanagnou, P. Galanos et al., “MKK7 and ARF: new players in the DNA damage response scenery,” Cell Cycle, vol. 13, no. 8, pp. 1227–1236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Genovés, F. Alameda, G. Mancebo et al., “Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study,” Human Pathology, vol. 45, no. 4, pp. 826–833, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Mikawa, T. Maruyama, K. Okamoto et al., “Senescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2,” The Journal of Cell Biology, vol. 204, pp. 729–745, 2014. View at Google Scholar
  53. M. Payton, S. Scully, G. Chung, and S. Coats, “Deregulation of Cyclin E2 expression and associated kinase activity in primary breast tumors,” Oncogene, vol. 21, no. 55, pp. 8529–8534, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Karst, P. M. Jones, N. Vena et al., “Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers,” Cancer Research, vol. 74, no. 4, pp. 1141–1152, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. J. J. Tyson and B. Novak, “Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions,” Journal of Theoretical Biology, vol. 210, no. 2, pp. 249–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Shiozaki, S. Nakashima, D. Ichikawa et al., “Prognostic significance of p21 expression in patients with esophageal squamous cell carcinoma,” Anticancer Research, vol. 33, no. 10, pp. 4329–4335, 2013. View at Google Scholar · View at Scopus
  57. K. Aoyagi, K. Kouhuji, M. Miyagi et al., “Expression of p27Kip1 protein in gastric carcinoma,” Hepato-Gastroenterology, vol. 60, no. 121, pp. 390–394, 2013. View at Google Scholar · View at Scopus
  58. X. Ma, Y. Gao, Y. Fan et al., “Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma,” PLoS ONE, vol. 8, no. 9, Article ID e73436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Massip, T. Arcondéguy, C. Touriol, C. Basset, H. Prats, and E. Lacazette, “E2F1 activates p53 transcription through its distal site and participates in apoptosis induction in HPV-positive cells,” FEBS Letters, vol. 587, no. 19, pp. 3188–3194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. R. C. Thompson, I. Vardinogiannis, and T. D. Gilmore, “The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity,” PLoS ONE, vol. 8, no. 5, Article ID e62822, 2013. View at Publisher · View at Google Scholar · View at Scopus